Inhibition of the HIV protease enzyme, which plays a key role in viral maturation, represents a promising therapeutic strategy for treatment of the escalating problem of HIV infection. 1-4 At Pharmacia & Upjohn we have developed two classes of low molecular weight HIV protease inhibitors,